Use of bisphosphonates in chronic kidney disease
Uso de bifosfonatos en la enfermedad renal crónica
Leído
42788
Vecesse ha leído el artículo
7699
Total PDF
35089
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 546 | 122 | 668 |
| 2025 11 | 1274 | 267 | 1541 |
| 2025 10 | 942 | 159 | 1101 |
| 2025 9 | 802 | 106 | 908 |
| 2025 8 | 861 | 182 | 1043 |
| 2025 7 | 969 | 113 | 1082 |
| 2025 6 | 950 | 322 | 1272 |
| 2025 5 | 1240 | 161 | 1401 |
| 2025 4 | 742 | 109 | 851 |
| 2025 3 | 861 | 182 | 1043 |
| 2025 2 | 792 | 112 | 904 |
| 2025 1 | 781 | 113 | 894 |
| 2024 12 | 592 | 70 | 662 |
| 2024 11 | 404 | 104 | 508 |
| 2024 10 | 429 | 85 | 514 |
| 2024 9 | 491 | 117 | 608 |
| 2024 8 | 450 | 142 | 592 |
| 2024 7 | 424 | 96 | 520 |
| 2024 6 | 415 | 123 | 538 |
| 2024 5 | 512 | 132 | 644 |
| 2024 4 | 349 | 116 | 465 |
| 2024 3 | 390 | 81 | 471 |
| 2024 2 | 380 | 107 | 487 |
| 2024 1 | 366 | 89 | 455 |
| 2023 12 | 333 | 80 | 413 |
| 2023 11 | 401 | 163 | 564 |
| 2023 10 | 455 | 154 | 609 |
| 2023 9 | 432 | 114 | 546 |
| 2023 8 | 473 | 110 | 583 |
| 2023 7 | 330 | 156 | 486 |
| 2023 6 | 254 | 99 | 353 |
| 2023 5 | 351 | 86 | 437 |
| 2023 4 | 211 | 141 | 352 |
| 2023 3 | 237 | 65 | 302 |
| 2023 2 | 180 | 66 | 246 |
| 2022 1 | 210 | 83 | 293 |
| 2022 12 | 161 | 55 | 216 |
| 2022 11 | 207 | 86 | 293 |
| 2022 10 | 149 | 79 | 228 |
| 2022 9 | 164 | 85 | 249 |
| 2022 8 | 176 | 93 | 269 |
| 2022 7 | 131 | 74 | 205 |
| 2022 6 | 181 | 87 | 268 |
| 2022 5 | 194 | 84 | 278 |
| 2022 4 | 154 | 93 | 247 |
| 2022 3 | 219 | 103 | 322 |
| 2022 2 | 153 | 97 | 250 |
| 2021 1 | 147 | 96 | 243 |
| 2021 12 | 126 | 81 | 207 |
| 2021 11 | 131 | 77 | 208 |
| 2021 10 | 157 | 90 | 247 |
| 2021 9 | 149 | 68 | 217 |
| 2021 8 | 144 | 77 | 221 |
| 2021 7 | 122 | 60 | 182 |
| 2021 6 | 128 | 46 | 174 |
| 2021 5 | 178 | 56 | 234 |
| 2021 4 | 468 | 138 | 606 |
| 2021 3 | 293 | 65 | 358 |
| 2021 2 | 210 | 37 | 247 |
| 2020 1 | 182 | 47 | 229 |
| 2020 12 | 155 | 43 | 198 |
| 2020 11 | 148 | 32 | 180 |
| 2020 10 | 127 | 32 | 159 |
| 2020 9 | 139 | 26 | 165 |
| 2020 8 | 141 | 22 | 163 |
| 2020 7 | 168 | 41 | 209 |
| 2020 6 | 113 | 31 | 144 |
| 2020 5 | 140 | 26 | 166 |
| 2020 4 | 103 | 20 | 123 |
| 2020 3 | 160 | 26 | 186 |
| 2020 2 | 263 | 39 | 302 |
| 2020 1 | 186 | 33 | 219 |
| 2019 12 | 119 | 33 | 152 |
| 2019 11 | 177 | 40 | 217 |
| 2019 10 | 141 | 21 | 162 |
| 2019 9 | 172 | 38 | 210 |
| 2019 8 | 104 | 26 | 130 |
| 2019 7 | 90 | 23 | 113 |
| 2019 6 | 112 | 38 | 150 |
| 2019 5 | 134 | 34 | 168 |
| 2019 4 | 185 | 50 | 235 |
| 2019 3 | 144 | 46 | 190 |
| 2019 2 | 89 | 35 | 124 |
| 2019 1 | 199 | 29 | 228 |
| 2018 12 | 190 | 57 | 247 |
| 2018 11 | 202 | 25 | 227 |
| 2018 10 | 205 | 16 | 221 |
| 2018 9 | 304 | 23 | 327 |
| 2018 8 | 194 | 34 | 228 |
| 2018 7 | 160 | 20 | 180 |
| 2018 6 | 150 | 15 | 165 |
| 2018 5 | 159 | 15 | 174 |
| 2018 4 | 154 | 10 | 164 |
| 2018 3 | 147 | 8 | 155 |
| 2018 2 | 110 | 8 | 118 |
| 2018 1 | 108 | 8 | 116 |
| 2017 12 | 141 | 15 | 156 |
| 2017 11 | 116 | 25 | 141 |
| 2017 10 | 106 | 6 | 112 |
| 2017 9 | 99 | 21 | 120 |
| 2017 8 | 122 | 23 | 145 |
| 2017 7 | 130 | 10 | 140 |
| 2017 6 | 156 | 21 | 177 |
| 2017 5 | 185 | 12 | 197 |
| 2017 4 | 125 | 13 | 138 |
| 2017 3 | 172 | 4 | 176 |
| 2017 2 | 194 | 18 | 212 |
| 2016 1 | 110 | 16 | 126 |
| 2016 12 | 140 | 12 | 152 |
| 2016 11 | 256 | 18 | 274 |
| 2016 10 | 285 | 30 | 315 |
| 2016 9 | 376 | 11 | 387 |
| 2016 8 | 506 | 12 | 518 |
| 2016 7 | 253 | 8 | 261 |
| 2016 6 | 183 | 0 | 183 |
| 2016 5 | 194 | 0 | 194 |
| 2016 4 | 180 | 0 | 180 |
| 2016 3 | 165 | 0 | 165 |
| 2016 2 | 165 | 0 | 165 |
| 2015 1 | 141 | 0 | 141 |
| 2015 12 | 152 | 0 | 152 |
| 2015 11 | 138 | 0 | 138 |
| 2015 10 | 129 | 0 | 129 |
| 2015 9 | 125 | 0 | 125 |
| 2015 8 | 107 | 0 | 107 |
| 2015 7 | 111 | 0 | 111 |
| 2015 6 | 34 | 0 | 34 |
| 2015 5 | 42 | 0 | 42 |
| 2015 4 | 6 | 0 | 6 |
Mostrar todo
